Safi U. Khan, MD, MS

Neighborhood-level SDoH’s—socioeconomic status, racial segregation & environmental factors—significantly impact CVD: “Zip Code Health Disparities: Mapping Cardiovascular Inequities at the Neighborhood Level” by @safinmc #DeBakeyCVJournal doi.org/10.14797/mdcvj… Earn free CME

📖In this single center study, #CTO #PCI was associated with improvement in #LVEF especially among patients with depressed baseline LVEF <50%. The improvements seemed to be more pronounced after CTO PCI of the LAD compared with other vessels 💡 Read more:…

🚨🚨 Our new paper out today in @JAMACardio: We examined hospital-level variability in achieving guideline-recommended treatment times for #STEMI across the U.S.—and how hospital performance, geography and case volume relate to outcomes. jamanetwork.com/journals/jamac… (Short thread 1/5)

Thank you, @safinmc, @ambarish4786 & @khurramn1, for the thoughtful discussion of our @JACCJournals paper on the efficacy of tirzepatide for cardiometabolic outcomes and its heterogeneous treatment effects across individuals. @rohan_khera @cards_lab @YaleCardiology @YaleIMed

Our @JACCJournals editorial discusses individual variability in cardiometabolic response to Tirzepatide (jacc.org/doi/10.1016/j.…) On the individual-level meta by Aminorroaya et al.: jacc.org/doi/10.1016/j.… @khurramn1, Ambarish @MethodistHosp

Excited to share my latest publication in @AJConline! Thank you, @safinmc, for the mentorship and opportunity. We analyzed 16,209 young adults (18–50) undergoing PCI for myocardial infarction (MI) between 2011–2023 using real-world TriNetX data.

Congrats @SaharSamimii @MethodistHosp @safinmc @KharsaChloe @Rody_BouChaaya @ffatimaqamar @Joe_Aoun_ @SyedZaidMD @NadeenFaza @SLittleMD @WilliamZoghbi @mdatkinsmd @MReardon19 NKleiman @khurramn1 @DipanJShah @almallahmo @HeartToProve @ChamsiPash @AlanLumsdenMD

I am glad to share our observational study, which adds to the growing evidence on beta-blockers post-PCI in the upcoming issue of @JACCJournals for stable CAD with preserved LVEF. Thank you, Dr. Safi Khan, for providing continuous mentorship. 📊 Key Findings: •Higher all-cause…

Beta-Blockers After PCI for Stable Coronary Artery Disease and Preserv... sciencedirect.com/science/articl… @HMethodistCV

Heart Disease in South Asians, Premature Heart Disease conversation with Rahul Menon of ⁦@DiasporaIndian⁩ youtube.com/watch?v=nNhvzW…

📢 New Study in @JACCJournals TAVR in high-risk patients with native AR: Dedicated devices (JenaValve/J-Valve) deliver: ✔️ Lower 30-day mortality ✔️ Higher device success ✔️ Fewer complications (residual AR, valve migration, PPI) Read more: sciencedirect.com/science/articl…

Elderly patient with mod/sev AS (AVA 0.9-1), severe LM bifurcation, RCA CTO, severe PAD with EVAR, iliac stents and femo-popliteal bypass ==> Impella assisted LM PCI using Mini-crush, no need for BAV @HMethodistCV @HMHCardioFellow @safinmc @SCAI #ACCFIT #Cardiotwitter #Cardiology

Cheers to @Rody_BouChaaya, @Taha_Hatab1, @SaharSamimii et al. & the leadership —Neal Kleiman, @AlpeshShahMD, @SachinGoelMD, @WilliamZoghbi—for creating the HM Young ACS-PCI Registry. A valuable resource for advancing care in young ACS patients! 📄: sciencedirect.com/science/articl…"

The Exposome & CV Health—new #DeBakeyCVJournal issue—published today! Special thanks to guest editors @Sadeer_AlKindi & @khurramn1 & our amazing authors @BasselTDaher @safinmc @hjryooali @anita_deswal @DrBunie et al journal.houstonmethodist.org @maquinonesmd @HMethodistCV @NadeenFaza

Our editorial — Enhancing Access to Transcatheter Tricuspid Interventions Amid Disparities | JACC: Advances jacc.org/doi/10.1016/j.… @SachinGoelMD @WilliamZoghbi @HMethodistCV @SLittleMD

1. Do patients with chronic kidney disease get similar quality of care as those without following admission with a heart attack in England and Wales? See here➡️ ahajournals.org/doi/epub/10.11… Our study led by @Nick1133 studies >350,000 pts from uk heart attack registry to assess this…

The long awaited return of the Houston Methodist Valve Journal Club. Just 26 friends and colleagues having a great dinner and discussing TAVR vs SAVR outcomes (non-inferiority) and durability. Thank you ⁦@IsaMathiasMD⁩ and ⁦@safinmc⁩ for a great discussion. ⁦#iEcho

🏭 Higher levels of long-term Particulate matter 2.5 (#AirQuality) exposure ⏯️ 🔺️🔺️🔺️#CVD ❤️, #Cancer & comorbid cancer+CVD #cardioonc mortality 🥀 Pronounced detrimental effect in vulnerable & minority population #AirPollution matters 🌍 #planetaryhealth is not…

Racial and ethnic disparities were observed for almost all leading causes of injury and disease that were associated with recent increases in youth mortality. ja.ma/3XjQNHl

“Humans” beyond borders!